The purpose of this study if to evaluate the efficacy and safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
Patient has given written informed consent to participate in the study prior to admission to the study;
Female patients aged between 16 and 35 years old, inclusive;
History of regular menstrual cycles, occuring between every 21 to 35 days;
Clinical history compatible with the diagnosis of primary dysmenorrhea;
Diagnosis of secondary dysmenorrhea;
History of non-response to treatment with non-steroidal anti-inflammatory drugs (NSAIDs) to relieve menstrual cramps;
Onset of primary dysmenorrhea after starting to use oral contraceptives;
Use of oral contraceptives for < 4 months prior to study selection;